The role of diuretic agents in the management of acute renal failure

Contributions to Nephrology

Volumn 132, Issue , 2001, Pages 158-170

  Venkataram, Ramesh ^a   Kellum, John A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; DIURETIC AGENT; DOPAMINE; OXYGEN;

ACUTE KIDNEY FAILURE; HUMAN; KIDNEY MEDULLA; KIDNEY TUBULE NECROSIS; METABOLISM; MORTALITY; RENAL REPLACEMENT THERAPY; REVIEW;

ATRIAL NATRIURETIC FACTOR; DIURETICS; DOPAMINE; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY MEDULLA; KIDNEY TUBULAR NECROSIS, ACUTE; OXYGEN; RENAL DIALYSIS;

EID: 0035532671     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060087     Document Type: Article

References (88)

1. Nissenson AR: Acute renal failure: Definition and pathogenesis. Kidney Int Suppl 1998;66:S7-S10.
2. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT: Hospital-acquired renal insufficiency: A prospective study. Am J Med 1983;74:243-248.
3. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ: Acute renal failure in intensive care units - Causes, outcome, and prognostic factors of hospital mortality: A prospective, multicenter study. French Study Group on Acute Renal Failure. Crit Care Med 1996;24:192-198.
4. Bellomo R, Ronco C: The changing pattern of severe acute renal failure. Nephrology 1991;2:602-610.
5. Brezis MEF: Pathophysiology of acute renal failure; in GR Hook JB (eds): Toxicology of the Kidney. New York, Raven Press, pp 129-152.
6. Heyman SN, Fuchs S, Brezis M: The role of medullary ischemia in acute renal failure. New Horiz 1995;3:597-607.
7. Brezis M, Rosen S, Spokes K, Silva P, Epstein FH: Transport-dependent anoxic cell injury in the isolated perfused rat kidney. Am J Pathol 1984;116:327-341.
8. Osswald H, Muhlbauer B, Schenk F: Adenosine mediates tubuloglomerular feedback response: An element of metabolic control of kidney function. Kidney Int Suppl 1991;32:S128-S131.
9. Shilliday I, Allison ME: Diuretics in acute renal failure. Ren Fail 1994;16:3-17.
10. Brezis M, Rosen S, Silva P, Epstein FH: Transport activity modifies thick ascending limb damage in the isolated perfused kidney. Kidney Int 1984;25:65-72.
11. Brezis M, Rosen SN, Epstein FH: The pathophysiological implications of medullary hypoxia. Am J Kidney Dis 1989;13:253-258.
12. Ludens JH, Hook JB, Brody MJ, Williamson HE: Enhancement of renal blood flow by furosemide. J Pharmacol Exp Ther 1968;163:456-460.
13. Stein JH: Acute renal failure. Lessons from pathophysiology. West J Med 1992;156:176-182.
14. Hager B, Betschart M, Krapf R: Effect of postoperative intravenous loop diuretic on renal function after major surgery. Schweiz Med Wochenschr 1996;126:666-673.
15. Solomon R, Werner C, Mann D, D'Elia J, Silva P: Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-1420.
16. Weinstein JM, Heyman S, Brezis M: Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 1992;62:413-415.
17. Cantarovich F, Fernandez JC, Locatelli A, Perez-Loredo J: Frusemide in high doses in the treatment of acute renal failure. Postgrad Med J 1971;47(suppl):13-17.
18. Borirakchanyavat V, Vongsthongsri M, Sitprija V: Furosemide and acute renal failure. Postgrad Med J 1978;54:30-32.
19. Brown CB, Ogg CS, Cameron JS: High-dose frusemide in acute renal failure: A controlled trial. Clin Nephrol 1981;15:90-96.
20. Singh NC, Kissoon N, AI Mofada S, Bennett M, Bohn DJ: Comparison of continuous versus intermittent furosemide administration in postoperative pediatric cardiac patients. Crit Care Med 1992;20:17-21.
21. Brown RS: Renal dysfunction in the surgical patient: Maintenance of high output state with furosemide. Crit Care Med 1979;7:63-68.
22. Minuth AN, Terrell JB Jr, Suki WN: Acute renal failure: A study of the course and prognosis of 104 patients and of the role of furosemide. Am J Med Sci 1976;271:317-324.
23. Kleinknecht D, Ganeval D, Gonzalez-Duque LA, Fermanian J: Furosemide in acute oliguric renal failure. A controlled trial. Nephron 1976;17:51-58.
24. Kelleher SP, Robinette JB, Conger JD: Sympathetic nervous system in the loss of autoregulation in acute renal failure. Am J Physiol 1984;246:F379-F386.
25. Kellum JA: Use of diuretics in the acute care setting. Kidney Int Suppl 1998;66:S67-S70.
26. Wright FS, Schnermann J: Interference with feedback control of glomerular filtration rate by furosemide, triflocin, and cyanide. J Clin Invest 1974;53:1695-1708.
27. Risler T, Kramer B, Muller GA: The efficacy of diuretics in acute and chronic renal failure. Focus on torasemide. Drugs 1991;41(suppl 3):69-79.
28. Rudy DW, Voelker JR, Greene PK, Esparza FA, Brater DC: Loop diuretics for chronic renal insufficiency: A continuous infusion is more efficacious than bolus therapy. Ann Intern Med 1991;115:360-366.
29. Dormans TP, Van Meyel JJ, Gerlag PG, Tan Y, Russel FG, Smits P: Diuretic efficacy of high-dose furosemide in severe heart failure: Bolus injection versus continuous infusion. J Am Coll Cardiol 1996;28:376-382.
30. Alkhunaizi AM, Schrier RW: Management of acute renal failure: New perspectives. Am J Kidney Dis 1996;28:315-328.
31. Kierdorf H, Sieberth HG: Continuous treatment modalities in acute renal failure. Nephrol Dial Transplant 1995;10:2001-2008.
32. Yeh BP, Tomko DJ, Stacy WK, Bear ES, Haden HT, Falls WF Jr: Factors influencing sodium and water excretion in uremic man. Kidney Int 1975;7:103-110.
33. Conger JD, Schultz MF, Miller F, Robinette JB: Responses to hemorrhagic arterial pressure reduction in different ischemic renal failure models. Kidney Int 1994;46:318-323.
34. Schulman G, Fogo A, Gung A, Badr K, Hakim R: Complement activation retards resolution of acute ischemic renal failure in the rat. Kidney Int 1991;40:1069-1074.
35. Morris CR, Alexander EA, Bruns FJ, Levinsky NG: Restoration and maintenance of glomerular filtration by mannitol during hypoperfusion of the kidney. J Clin Invest 1972;51:1555-1564.
36. Hansson R, Jonsson O, Lundstam S, Pettersson S, Schersten T, Waldenstrom J: Effects of free radical scavengers on renal circulation after ischaemia in the rabbit. Clin Sci 1983;65:605-610.
37. Burke TJ, Cronin RE, Duchin KL, Peterson LN, Schrier RW: Ischemia and tubule obstruction during acute renal failure in dogs: Mannitol in protection. Am J Physiol 1980;238:F305-F314.
38. Cronin RE, De Torrente A, Miller PD, Bulger RE, Burke TJ, Schrier RW: Pathogenic mechanisms in early norepinephrine-induced acute renal failure: Functional and histological correlates of protection. Kidney Int 1978;14:115-125.
39. Beall AC, Holman MR, Morris GC, et al: Mannitol-induced osmotic diuresis during vascular surgery. Arch Surg 1963;86:34-42.
40. Powers SR, Boba A, Hostnik W, et al: Prevention of postoperative acute renal failure with mannitol in 100 cases. Surgery 1964;35:15-23.
41. Ip-Yam PC, Murphy S, Baines M, Fox MA, Desmond MJ, Innes PA: Renal function and proteinuria after cardiopulmonary bypass: The effects of temperature and mannitol. Anesth Analg 1994;78:842-847.
42. Gubern JM, Sancho JJ, Simo J, Sitges-Serra A: A randomized trial on the effect of mannitol on postoperative renal function in patients with obstructive jaundice. Surgery 1988;103:39-44.
43. Dawson JL: Post-operative renal function in obstructive jaundice: Effect of a mannitol diuresis. Br Med J 1965;i:82-86.
44. Wilson DR, Thiel G, Arce ML, Oken GE: Glycerol-induced hemoglobinuric acute renal failure in the rat. 3. Micropuncture study of the effects of mannitol and isotonic saline on individual nephron function. Nephron 1967;4:337-355.
45. Ron D, Taitelman U, Michaelson M, Bar-Joseph G, Bursztein S, Better OS: Prevention of acute renal failure in traumatic rhabdomyolysis. Arch Intern Med 1984;144:277-280.
46. Homsi E, Barreiro MF, Orlando JM, Higa EM: Prophylaxis of acute renal failure in patients with rhabdomyolysis. Ren Fail 1997;19:283-288.
47. Kelum JA: The use of diuretics and dopamine in acute renal failure: A systematic review of the evidence. Critical Care 1997;1:53-59.
48. +-ATPase activity in rat renal cortical tubule cells. Am J Physiol 1988;255:F666-F673.
49. Heyman SN, Kaminski N, Brezis M: Dopamine increases renal medullary blood flow without improving regional hypoxia. Exp Nephrol 1995;3:331-337.
50. Olsen NV, Hansen JM, Ladefoged SD, Fogh-Andersen N, Leyssac PP: Renal tubular reabsorption of sodium and water during infusion of low-dose dopamine in normal man. Clin Sci (Colch) 1990;78:503-507.
51. Hall KA, Wong RW, Hunter GC, Camazine BM, Rappaport WA, Smyth SH, Bull DA, McIntyre KE, Bernhard VM, Misiorowski RL: Contrast-induced nephrotoxicity: The effects of vasodilator therapy. J Surg Res 1992;53:317-320.
52. Palmieri G, Morabito A, Lauria R, Montesarchio V, Matano E, Memoli B, Libetta C, Rea A, Merola C, Correale P, Leo I, Tagliaferri P, Bianco AR: Low-dose dopamine induces early recovery of recombinant interleukin-2-impaired renal function. Eur J Cancer 1993;29:1119-1122.
53. Polson RJ, Park GR, Lindop MJ, Farman JV, Calne RY, Williams R: The prevention of renal impairment in patients undergoing orthotopic liver grafting by infusion of low-dose dopamine. Anaesthesia 1987;42:15-19.
54. Swygert TH, Roberts LC, Valek TR, Brajtbord D, Brown MR, Gunning TC, Paulsen AW, Ramsay MA: Effect of intraoperative low-dose dopamine on renal function in liver transplant recipients. Anesthesiology 1991;75:571-576.
55. Lherm T, Troche G, Rossignol M, Bordes P, Zazzo JF: Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines. Intensive Care Med 1996;22:213-219.
56. Denton MD, Chertow GM, Brady HR: 'Renal-dose' dopamine for the treatment of acute renal failure: Scientific rationale, experimental studies and clinical trials. Kidney Int 1996;50:4-14.
57. Segal JM, Phang PT, Walley KR: Low-dose dopamine hastens onset of gut ischemia in a porcine model of hemorrhagic shock. J Appl Physiol 1992;73:1159-1164.
58. Greene SI, Smith JW: Dopamine gangrene (letter). N Engl J Med 1976;294:114.
59. Allison NL, Dubb JW, Ziemniak JA, Alexander F, Stole RM: The effect of fenoldopam, a dopaminergic agonist, on renal hemodynamics. Clin Pharmacol Ther 1987;41:282-288.
60. Elliott WJ, Weber RR, Nelson KS, Oliner CM, Fumo MT, Gretler DD, McCray GR, Murphy MB: Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension. Circulation 1990;81:970-977.
61. Carey RA, Weidley EF, Ackerman DM: Effect of SK and F82526 on renal vascular resistance following acute myocardial infarction in the dog (abstract). Fed Proc 1982;41:1092.
62. Jorkasky DK, Audet P, Shusterman N, Ilson B, Dafoe D, Hedrich D, Stole RM: Fenoldopam reverses cyclosporine-induced renal vasoconstriction in kidney transplant recipients. Am J Kidney Dis 1992;19:567-572.
63. Nichols AJ, Koster PF, Brooks DP, Ruffolo RR Jr: Effect of fenoldopam on the acute and sub-acute nephrotoxic renal failure produced by amphotericine B in the dog. J Pharmacol Exp Ther 1992;260:269-274.
64. Shusterman NH, Elliott WJ, White WB: Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function. Am J Med 1993;95:161-168.
65. Shuster HP, Suter PM, Hemmer M, Clemens R, Bodman KF, Raymond J: Fenoldopam improves renal dysfunction secondary to ventilation with PEEP. Intensive Med 1991;28:348-355.
66. Munger MA, Benotti JR, Green JA, Jarvis RC, Nara AR, McCue JE, Pospisil RA, Kasmer RJ: Assessment of hemodynamic tolerance from a 24-hour intravenous infusion of fenoldopam mesylate in congestive heart failure. Am J Cardiol 1990;65:206-210.
67. Hadengue A, Moreau R, Bacq Y, Braillon A, Lebrec D: Selective dopamine receptor-1 stimulation with fenoldopam in cirrhotic patients with ascites: A systemic, splanchnic and renal hemodynamic study. Hepatology 1991;13:111-116.
68. Mathurs VS, Swan SK, Lambrecht LJ, Anjum S, Fellmann J, McGuire D, Epstein M, Luther RR: The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 1999;27:1832-1837.
69. Napier MA, Vandlen RL, Albers-Schonberg G, Nutt RF, Brady S, Lyle T, Winquist R, Faison EP, Heinel LA, Blaine EH: Specific membrane receptors for atrial natriuretic factor in renal and vascular tissues. Proc Natl Sci USA 1984;81:5946-5950.
70. Dunn BR, Ichikawa I, Pfeffer JM, Troy JL, Brenner BM: Renal and systemic hemodynamic effects of synthetic atrial natriuretic peptide in the anesthetized rat. Circ Res 1986;59:237-246.
71. Sonnenberg H, Honrath U, Chong CK, Wilson DR: Atrial natriuretic factor inhibits sodium transport in medullary collecting duct. Am J Physiol 1986;250:F963-F969.
72. Shafferhans K, Heidbreder E, Grim D, et al: Norepinephrine-induced acute renal failure; beneficial effects of atrial natriuretic factor. Nephron 1986;44:240-244.
73. Conger JD, Falk SA, Yuan BH, Schrier RW: Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure. Kidney Int 1989;35:1126-1132.
74. Capasso G, Anastasio P, Giordano D, Albarano L, De Santo NG: Beneficial effects of atrial natriuretic factor on cisplatin-induced acute renal failure in the rat. Am J Nephrol 1987;7:228-234.
75. Gianello P, Ramboux A, Poelart D, Jamart J, Berbinschi A, Donckier J, Ketelslegers JM, Lambotte L, Squifflet JP, Alexandre GP: Prevention of acute cyclosporine nephrotoxicity by atrial natriuretic factor after ischemia in the rat. Transplantation 1989;47:512-515.
76. Schafferhans K, Heidbreder E, Sperber S, Dammrich J, Heidland A: Atrial natriuretic peptide in gentamicin-induced acute renal failure. Kidney Int Suppl 1988;25:S101-S103.
77. Bently MD, Fiksen-Olsen MJ, Romero JC: Effect of atriopeptin II on contrast medium-induced changes in renal blood flow. Kidney Int 1989;36:13-19.
78. Rahman SN, Kim GE, Mathew AS, Goldberg CA, Allgren R, Schrier RW, Conger JD: Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int 1994;45:1731-1738.
79. Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Center FC, Kurnik BR, Conger JD, Sayegh MH: Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 1997;336:828-834.
80. Allgren RL: Update on clinical trials with atrial natriuretic peptide in acute tubular necrosis. Ren Fail 1998;20:691-695.
81. Kurnik BR, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weisberg LS: Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 1998;31:674-680.
82. Valsson F, Ricksten SE, Hedner T, Lundin S: Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery. Intensive Care Med 1996;22:230-236.
83. Sands JM, Neylan JF, Olson RA, O'Brien DP, Whelchel JD, Mitch WE: Atrial natriuretic factor does not improve the outcome of cadaveric renal transplantation. J Am Soc Nephrol 1991;1:1081-1086.
84. Saxenhofer H, Raselli A, Weidmann P, Forssmann WG, Bub A, Ferrari P, Shaw SG: Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men. Am J Physiol 1990;259:F832-D838.
85. Hummel M, Kuhn M, Bub A, Bittner H, Kleefeld D, Marxen P, et al: Urodilatin: A new peptide with beneficial effects in post-operative therapy on cardiac transplant recipients. Clin Invest 1992;70:647-682.
86. Wiebe K, Meyer M, Wahlers T, Zenker D, Schulze F, Michels P, Dalichau H, Mohr FW, Borst H, Forssmann WG: Acute renal failure following cardiac surgery is reverted by administration of urodilatin(INN: Ularitide). Eur J Med Res 1996;1:259-265.
87. Cedidi C, Meyer M, Kuse ER, Schulz-Knappe P, Ringe B, Frei U, Pichlmayr R, Forssmann WG: Urodilatin: A new approach for the treatment of therapy-resistant acute renal failure after liver transplantation. Eur J Clin Invest 1994;24:632-639.
88. Meyer M, Pfarr E, Schirmer G, Uberbacher HJ, Schope K, Bohm E, Fluge T, Mentz P, Scigalla P, Forssmann WG: Therapeutic use of the natriuretic peptide ularitide in acute renal failure. Ren Fail 1999;21:85-100.